Suppr超能文献

危重症儿童需要肾脏替代治疗的死亡风险因素。

Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy.

机构信息

Division of Cardiovascular Critical Care, Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA.

Division of Nephrology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA.

出版信息

Pediatr Crit Care Med. 2019 Nov;20(11):1069-1077. doi: 10.1097/PCC.0000000000002045.

Abstract

OBJECTIVES

There is an increased mortality risk in critically ill children who require renal replacement therapy for acute kidney injury and fluid overload. Nevertheless, renal replacement therapy is essential in managing these patients. The objective of this study was to identify risk factors for mortality in critically ill children requiring renal replacement therapy.

DESIGN

Single-center, retrospective cohort analysis.

SETTING

Tertiary care children's hospital.

PATIENTS

All patients admitted to an ICU at Boston Children's Hospital from January 2009 to December 2017 who required any form of renal replacement therapy.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Four-hundred sixty-three patients required inpatient renal replacement therapy over the study period. Of these, there were 98 patients who had 99 unique encounters for renal replacement therapy that met eligibility criteria for analysis. The most common diagnoses were respiratory failure, stem cell transplant, and sepsis. The overall mortality was 55.6%. Nonsurvivors had a lower ICU admission weight compared with survivors (30.0 kg vs 44.0 kg; p = 0.037) and a higher degree of fluid accumulation at the time of renal replacement therapy initiation (17.1% vs 8.1%; p = 0.021). In multivariable logistic regression analysis, invasive mechanical ventilation (odds ratio, 7.22; 95% CI, 1.88-27.7), a longer duration of stage 3 acute kidney injury (odds ratio, 1.08; 95% CI, 1.02-1.15), and higher fluid balance in the 72 hours after initiating renal replacement therapy (odds ratio, 1.12; 95% CI, 1.05-1.20) were associated with an increased odds of mortality.

CONCLUSIONS

Earlier renal replacement therapy initiation with respect to the development of severe acute kidney injury was associated with lower mortality in this cohort of critically ill children. Additionally, invasive mechanical ventilation at the time of renal replacement therapy initiation and a higher degree of fluid accumulation after initiating renal replacement therapy were associated with increased mortality.

摘要

目的

在需要肾脏替代疗法治疗急性肾损伤和液体超负荷的危重病儿童中,死亡率风险增加。然而,肾脏替代疗法对于治疗这些患者至关重要。本研究的目的是确定需要肾脏替代疗法的危重病儿童死亡的危险因素。

设计

单中心回顾性队列分析。

地点

三级儿童保健医院。

患者

2009 年 1 月至 2017 年 12 月期间入住波士顿儿童医院 ICU 的所有需要任何形式肾脏替代疗法的患者。

干预措施

无。

测量和主要结果

在研究期间,有 463 名患者需要住院肾脏替代治疗。其中,有 98 名患者因肾脏替代治疗有 99 次独特的就诊经历,符合分析的纳入标准。最常见的诊断是呼吸衰竭、干细胞移植和败血症。总体死亡率为 55.6%。与幸存者相比,非幸存者的 ICU 入院体重较低(30.0kg 与 44.0kg;p=0.037),肾脏替代治疗开始时的液体蓄积程度更高(17.1%与 8.1%;p=0.021)。多变量逻辑回归分析显示,有创机械通气(比值比,7.22;95%置信区间,1.88-27.7)、3 期急性肾损伤持续时间较长(比值比,1.08;95%置信区间,1.02-1.15)和肾脏替代治疗开始后 72 小时内液体平衡更高(比值比,1.12;95%置信区间,1.05-1.20)与死亡率增加相关。

结论

在本危重病儿童队列中,与严重急性肾损伤发生相比,更早开始肾脏替代治疗与死亡率降低相关。此外,肾脏替代治疗开始时的有创机械通气和开始后液体蓄积程度更高与死亡率增加相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验